腫瘍プロファイリングの世界市場レポート 2025年

腫瘍プロファイリング市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.1％で164億8,000万米ドルに成長します。予測期間中に予想される成長は、リキッドバイオプシー技術の採用の増加、がん研究開発への投資の増加、高齢化、標的療法の使用拡大、がん研究協力の増加などの要因によるものと考えられます。この期間を形成すると予想される主な動向には、コンパニオン診断へのシフト、複数遺伝子検査の増加、次世代シーケンシングの技術革新、がん診断における人工知能（AI）の統合、腫瘍プロファイリング技術の進歩などがあります。

個別化医療に対する需要の高まりは、今後数年間の腫瘍プロファイリング市場の成長を促進すると予想されます。個別化医療は、ヘルスケア治療を患者一人ひとりの特徴に合わせて調整するもので、従来の治療と比較して、より良い結果と副作用の少ない、より正確な治療を提供します。腫瘍プロファイリングは、患者の腫瘍における特定の遺伝子変異やバイオマーカーを特定し、副作用を最小限に抑える標的治療を可能にすることで、個別化医療において重要な役割を果たしています。例えば、2024年2月、米国を拠点に個別化医療を推進する組織である個別化医療連合（Personalized Medicine Coalition）は、2023年の新薬承認件数に占める個別化医療の割合が3分の1を超え、この傾向は4年連続であると報告しました。その結果、個別化医療に対する需要の高まりが腫瘍プロファイリング市場の拡大を後押ししています。

腫瘍プロファイリング市場の主要企業は、がん治療の精度と効率を向上させるため、人工知能（AI）を搭載した診断ツールを含む先進的ソリューションの開発にますます注力しています。AIには、複雑なゲノム、プロテオーム、臨床データを分析するための高度な計算技術が含まれ、より迅速な診断、個別化された治療計画、より良い病状進行のモニタリングが容易になります。例えば、2025年1月、がん診断・治療のためのAI駆動型ソフトウェアを専門とする英国のPanakeia Technologies LTDは、PANProfiler Colonを発表しました。このAI搭載ソフトウェアは、大腸がん組織サンプルのHおよびE染色画像を用いて、マイクロサテライト不安定性（MSI）やミスマッチ修復欠損（dMMR）などの主要分子バイオマーカーをプロファイリングするよう特別に設計されています。このツールにより、腫瘍の迅速かつ正確な分子プロファイリングが可能となり、大腸がんの診断、リンチ症候群の同定、個別化治療の決定に極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腫瘍プロファイリング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腫瘍プロファイリング市場：成長率分析
• 世界の腫瘍プロファイリング市場の実績：規模と成長, 2019-2024
• 世界の腫瘍プロファイリング市場の予測：規模と成長, 2024-2029, 2034F
• 世界腫瘍プロファイリング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腫瘍プロファイリング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノミクス
• プロテオミクス
• エピジェネティクス
• メタボロミクス
• 世界の腫瘍プロファイリング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シーケンシング技術
• 定量的ポリメラーゼ連鎖反応（qPCR）
• 免疫組織化学
• インサイチューハイブリダイゼーション（ISH）
• マイクロアレイ
• 世界の腫瘍プロファイリング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 個別化がん医療
• 腫瘍診断
• 調査
• 世界の腫瘍プロファイリング市場、ゲノミクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 次世代シーケンシング（NGS）
• ポリメラーゼ連鎖反応（PCR）
• マイクロアレイ
• サンガーシーケンス
• 世界の腫瘍プロファイリング市場プロテオミクスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 質量分析（MS）
• タンパク質マイクロアレイ
• 免疫組織化学（IHC）
• ウェスタンブロッティング
• 世界の腫瘍プロファイリング市場エピジェネティクスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAメチル化分析
• クロマチン免疫沈降シーケンス（ChIP-seq）
• ヒストン修飾プロファイリング
• 非コードRNA解析
• 世界の腫瘍プロファイリング市場メタボロミクスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核磁気共鳴（NMR）分光法
• ガスクロマトグラフィー質量分析法（GC-MS）
• 液体クロマトグラフィー質量分析法（LC-MS）
• キャピラリー電気泳動質量分析法（CE-MS）

第7章 地域別・国別分析

• 世界の腫瘍プロファイリング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腫瘍プロファイリング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腫瘍プロファイリング市場：競合情勢
• 腫瘍プロファイリング市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• Guardant Health Inc.
• GenScript Biotech Corporation
• NeoGenomics Inc.
• Caris Life Sciences Inc.
• Tempus Inc.
• Foundation Medicine Inc.
• NanoString Technologies Inc.
• Personalis Inc.
• Boreal Genomics Inc.
• Strand Life Sciences Pvt. Ltd.
• HTG Molecular Diagnostics Inc.
• Lucence Health Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腫瘍プロファイリング市場2029：新たな機会を提供する国
• 腫瘍プロファイリング市場2029：新たな機会を提供するセグメント
• 腫瘍プロファイリング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tumor profiling is a collection of methods used to examine and characterize the genetic and molecular characteristics of a tumor. This process helps identify specific mutations, gene expression patterns, and other molecular traits of cancer cells, providing valuable insights into the biology of the tumor. It also aids in treatment decision-making and supports the development of personalized therapies.

The primary techniques used in tumor profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics involves studying the genetic material (DNA) of cancer cells to identify genetic alterations that drive tumor formation and progression. It uses technologies such as sequencing, quantitative polymerase chain reaction (qPCR), immunohistochemistry, in situ hybridization (ISH), and microarrays. These techniques are commonly applied in personalized cancer treatment, oncological diagnostics, and research.

The tumor profiling market research report is one of a series of new reports from The Business Research Company that provides tumor profiling market statistics, including tumor profiling industry global market size, regional shares, competitors with a tumor profiling market share, detailed tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor profiling industry. This tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor profiling market size has grown rapidly in recent years. It will grow from $10.16 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer cases, growing demand for personalized medicine, increased healthcare spending, wider adoption of companion diagnostics, and heightened awareness of the importance of early cancer detection.

The tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated during the forecast period can be attributed to factors such as the increasing adoption of liquid biopsy techniques, rising investments in cancer research and development, an aging population, the expanding use of targeted therapies, and a growing number of cancer research collaborations. Key trends expected to shape this period include a shift toward companion diagnostics, an increase in multi-gene testing, technological innovations in next-generation sequencing, the integration of artificial intelligence (AI) in cancer diagnostics, and advancements in tumor profiling technologies.

The growing demand for personalized medicine is expected to fuel the growth of the tumor profiling market in the coming years. Personalized medicine tailors healthcare treatments to the unique characteristics of each patient, offering more precise therapies with better outcomes and fewer side effects compared to traditional treatments. Tumor profiling plays a key role in personalized medicine by identifying specific genetic mutations and biomarkers in a patient's tumor, enabling targeted therapies that minimize side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based organization focused on advancing personalized medicine, reported that personalized medicines accounted for over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. As a result, the rising demand for personalized medicine is driving the expansion of the tumor profiling market.

Leading companies in the tumor profiling market are increasingly focusing on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to improve the accuracy and efficiency of cancer treatment. AI involves the use of advanced computational techniques to analyze complex genomic, proteomic, and clinical data, facilitating faster diagnoses, personalized treatment plans, and better disease progression monitoring. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), using H and E-stained images of colon cancer tissue samples. The tool allows for rapid and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying Lynch syndrome, and guiding personalized treatment decisions.

In February 2024, Myriad Genetics Inc., a U.S.-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG) for an undisclosed amount. This acquisition bolsters Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and its CLIA-certified laboratory in St. George, Utah, all aimed at advancing patient care. Intermountain Precision Genomics is a US-based division specializing in molecular diagnostics, genomic testing, and tumor profiling.

Major players in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor profiling market includes revenues earned by entities by providing services such as biomarker testing, methylation profiling, and clinical trial matching. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor profiling market also includes sales of liquid biopsy kits, immunohistochemistry (IHC) kits, and methylation profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
• 2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
• 3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
• Subsegments:
• 1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
• 2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
• 3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
• 4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Profiling Market Characteristics

3. Tumor Profiling Market Trends And Strategies

4. Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tumor Profiling Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tumor Profiling Market Growth Rate Analysis
• 5.4. Global Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tumor Profiling Total Addressable Market (TAM)

6. Tumor Profiling Market Segmentation

• 6.1. Global Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomics
• Proteomics
• Epigenetics
• Metabolomics
• 6.2. Global Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Techniques
• Quantitative Polymerase Chain Reaction (qPCR)
• Immunohistochemistry
• In Situ Hybridization (ISH)
• Microarray
• 6.3. Global Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Personalized Cancer Medicine
• Oncological Diagnostics
• Research
• 6.4. Global Tumor Profiling Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarrays
• Sanger sequencing
• 6.5. Global Tumor Profiling Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectrometry (MS)
• Protein Microarrays
• Immunohistochemistry (IHC)
• Western Blotting
• 6.6. Global Tumor Profiling Market, Sub-Segmentation Of Epigenetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methylation Analysis
• Chromatin Immunoprecipitation Sequencing (ChIP-seq)
• Histone Modification Profiling
• Non-Coding RNA Analysis
• 6.7. Global Tumor Profiling Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nuclear Magnetic Resonance (NMR) Spectroscopy
• Gas Chromatography-Mass Spectrometry (GC-MS)
• Liquid Chromatography-Mass Spectrometry (LC-MS)
• Capillary Electrophoresis-Mass Spectrometry (CE-MS)

7. Tumor Profiling Market Regional And Country Analysis

• 7.1. Global Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Profiling Market

• 8.1. Asia-Pacific Tumor Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Profiling Market

• 9.1. China Tumor Profiling Market Overview
• 9.2. China Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Profiling Market

• 10.1. India Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Profiling Market

• 11.1. Japan Tumor Profiling Market Overview
• 11.2. Japan Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Profiling Market

• 12.1. Australia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Profiling Market

• 13.1. Indonesia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Profiling Market

• 14.1. South Korea Tumor Profiling Market Overview
• 14.2. South Korea Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Profiling Market

• 15.1. Western Europe Tumor Profiling Market Overview
• 15.2. Western Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Profiling Market

• 16.1. UK Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Profiling Market

• 17.1. Germany Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Profiling Market

• 18.1. France Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Profiling Market

• 19.1. Italy Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Profiling Market

• 20.1. Spain Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Profiling Market

• 21.1. Eastern Europe Tumor Profiling Market Overview
• 21.2. Eastern Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Profiling Market

• 22.1. Russia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Profiling Market

• 23.1. North America Tumor Profiling Market Overview
• 23.2. North America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Profiling Market

• 24.1. USA Tumor Profiling Market Overview
• 24.2. USA Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Profiling Market

• 25.1. Canada Tumor Profiling Market Overview
• 25.2. Canada Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Profiling Market

• 26.1. South America Tumor Profiling Market Overview
• 26.2. South America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Profiling Market

• 27.1. Brazil Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Profiling Market

• 28.1. Middle East Tumor Profiling Market Overview
• 28.2. Middle East Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Profiling Market

• 29.1. Africa Tumor Profiling Market Overview
• 29.2. Africa Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Profiling Market Competitive Landscape And Company Profiles

• 30.1. Tumor Profiling Market Competitive Landscape
• 30.2. Tumor Profiling Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Profiling Market Other Major And Innovative Companies

• 31.1. Sysmex Corporation
• 31.2. QIAGEN N.V.
• 31.3. Exact Sciences Corporation
• 31.4. Guardant Health Inc.
• 31.5. GenScript Biotech Corporation
• 31.6. NeoGenomics Inc.
• 31.7. Caris Life Sciences Inc.
• 31.8. Tempus Inc.
• 31.9. Foundation Medicine Inc.
• 31.10. NanoString Technologies Inc.
• 31.11. Personalis Inc.
• 31.12. Boreal Genomics Inc.
• 31.13. Strand Life Sciences Pvt. Ltd.
• 31.14. HTG Molecular Diagnostics Inc.
• 31.15. Lucence Health Inc.

32. Global Tumor Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Profiling Market

34. Recent Developments In The Tumor Profiling Market

35. Tumor Profiling Market High Potential Countries, Segments and Strategies

• 35.1 Tumor Profiling Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tumor Profiling Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tumor Profiling Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer